Stay updated on Dolutegravir in Pregnancy Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir in Pregnancy Clinical Trial page.

Latest updates to the Dolutegravir in Pregnancy Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe webpage has undergone significant updates, including the removal of detailed descriptions of a clinical trial evaluating dolutegravir (DTG) efficacy in pregnant women with untreated HIV, while adding new references to the trial's revision and its open-label, multi-centre nature.SummaryDifference26%
- Check42 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 21, 2025.SummaryDifference0.4%
- Check49 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check85 days agoChange DetectedThe page has been updated with new dates for future events and removed outdated information regarding service availability and a specific individual.SummaryDifference3%
- Check100 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to Dolutegravir in Pregnancy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir in Pregnancy Clinical Trial page.